ARTIVION INC (AORT) Fundamental Analysis & Valuation

NYSE:AORT • US2289031005

Current stock price

34.78 USD
+1.33 (+3.98%)
Last:

This AORT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. AORT Profitability Analysis

1.1 Basic Checks

  • AORT had positive earnings in the past year.
  • AORT had a positive operating cash flow in the past year.
  • AORT had negative earnings in 4 of the past 5 years.
  • In multiple years AORT reported negative operating cash flow during the last 5 years.
AORT Yearly Net Income VS EBIT VS OCF VS FCFAORT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

1.2 Ratios

  • With a decent Return On Assets value of 1.10%, AORT is doing good in the industry, outperforming 72.87% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 2.18%, AORT is in the better half of the industry, outperforming 73.40% of the companies in the same industry.
  • AORT's Return On Invested Capital of 2.26% is fine compared to the rest of the industry. AORT outperforms 69.15% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for AORT is significantly below the industry average of 9.40%.
Industry RankSector Rank
ROA 1.1%
ROE 2.18%
ROIC 2.26%
ROA(3y)-1.48%
ROA(5y)-1.76%
ROE(3y)-4.5%
ROE(5y)-5.02%
ROIC(3y)2.51%
ROIC(5y)N/A
AORT Yearly ROA, ROE, ROICAORT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10

1.3 Margins

  • AORT has a better Profit Margin (2.21%) than 73.40% of its industry peers.
  • AORT's Operating Margin of 6.06% is fine compared to the rest of the industry. AORT outperforms 71.81% of its industry peers.
  • In the last couple of years the Operating Margin of AORT has grown nicely.
  • AORT has a Gross Margin of 64.40%. This is in the better half of the industry: AORT outperforms 69.68% of its industry peers.
  • AORT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.06%
PM (TTM) 2.21%
GM 64.4%
OM growth 3YN/A
OM growth 5Y12.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.07%
GM growth 5Y-0.57%
AORT Yearly Profit, Operating, Gross MarginsAORT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. AORT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AORT is destroying value.
  • The number of shares outstanding for AORT has been increased compared to 1 year ago.
  • The number of shares outstanding for AORT has been increased compared to 5 years ago.
  • AORT has a better debt/assets ratio than last year.
AORT Yearly Shares OutstandingAORT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AORT Yearly Total Debt VS Total AssetsAORT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 3.07 indicates that AORT is not in any danger for bankruptcy at the moment.
  • AORT's Altman-Z score of 3.07 is fine compared to the rest of the industry. AORT outperforms 68.62% of its industry peers.
  • AORT has a debt to FCF ratio of 260.47. This is a negative value and a sign of low solvency as AORT would need 260.47 years to pay back of all of its debts.
  • AORT's Debt to FCF ratio of 260.47 is fine compared to the rest of the industry. AORT outperforms 66.49% of its industry peers.
  • AORT has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
  • AORT's Debt to Equity ratio of 0.49 is in line compared to the rest of the industry. AORT outperforms 41.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 260.47
Altman-Z 3.07
ROIC/WACC0.26
WACC8.7%
AORT Yearly LT Debt VS Equity VS FCFAORT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 3.53 indicates that AORT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.53, AORT is in line with its industry, outperforming 58.51% of the companies in the same industry.
  • AORT has a Quick Ratio of 2.62. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
  • AORT has a Quick ratio (2.62) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.53
Quick Ratio 2.62
AORT Yearly Current Assets VS Current LiabilitesAORT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. AORT Growth Analysis

3.1 Past

  • AORT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 141.86%, which is quite impressive.
  • Measured over the past years, AORT shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.78% on average per year.
  • Looking at the last year, AORT shows a quite strong growth in Revenue. The Revenue has grown by 13.59% in the last year.
  • The Revenue has been growing by 11.75% on average over the past years. This is quite good.
EPS 1Y (TTM)141.86%
EPS 3YN/A
EPS 5Y-4.78%
EPS Q2Q%112.82%
Revenue 1Y (TTM)13.59%
Revenue growth 3Y12.04%
Revenue growth 5Y11.75%
Sales Q2Q%19.2%

3.2 Future

  • The Earnings Per Share is expected to grow by 70.33% on average over the next years. This is a very strong growth
  • AORT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.25% yearly.
EPS Next Y102.54%
EPS Next 2Y107.21%
EPS Next 3Y69.87%
EPS Next 5Y70.33%
Revenue Next Year11.86%
Revenue Next 2Y11.51%
Revenue Next 3Y11.73%
Revenue Next 5Y12.25%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AORT Yearly Revenue VS EstimatesAORT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
AORT Yearly EPS VS EstimatesAORT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. AORT Valuation Analysis

4.1 Price/Earnings Ratio

  • AORT is valuated quite expensively with a Price/Earnings ratio of 193.22.
  • Based on the Price/Earnings ratio, AORT is valued a bit cheaper than the industry average as 64.36% of the companies are valued more expensively.
  • AORT is valuated expensively when we compare the Price/Earnings ratio to 26.21, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 95.40 indicates a quite expensive valuation of AORT.
  • AORT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AORT is cheaper than 66.49% of the companies in the same industry.
  • AORT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.13.
Industry RankSector Rank
PE 193.22
Fwd PE 95.4
AORT Price Earnings VS Forward Price EarningsAORT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AORT is valued a bit cheaper than the industry average as 68.09% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 66.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1984.82
EV/EBITDA 35.67
AORT Per share dataAORT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as AORT's earnings are expected to grow with 69.87% in the coming years.
PEG (NY)1.88
PEG (5Y)N/A
EPS Next 2Y107.21%
EPS Next 3Y69.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AORT Dividend Analysis

5.1 Amount

  • AORT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AORT Fundamentals: All Metrics, Ratios and Statistics

ARTIVION INC

NYSE:AORT (4/7/2026, 1:21:11 PM)

34.78

+1.33 (+3.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)04-30
Inst Owners88.38%
Inst Owner Change0%
Ins Owners4.23%
Ins Owner Change5.62%
Market Cap1.67B
Revenue(TTM)441.33M
Net Income(TTM)9.76M
Analysts83.08
Price Target52.46 (50.83%)
Short Float %3.82%
Short Ratio3.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)101.61%
Min EPS beat(2)-39.98%
Max EPS beat(2)243.19%
EPS beat(4)3
Avg EPS beat(4)555.79%
Min EPS beat(4)-39.98%
Max EPS beat(4)1928.24%
EPS beat(8)5
Avg EPS beat(8)220.91%
EPS beat(12)7
Avg EPS beat(12)112.9%
EPS beat(16)11
Avg EPS beat(16)108.2%
Revenue beat(2)0
Avg Revenue beat(2)-1.72%
Min Revenue beat(2)-2.32%
Max Revenue beat(2)-1.12%
Revenue beat(4)2
Avg Revenue beat(4)0.33%
Min Revenue beat(4)-2.32%
Max Revenue beat(4)2.59%
Revenue beat(8)3
Avg Revenue beat(8)-0.34%
Revenue beat(12)7
Avg Revenue beat(12)0.64%
Revenue beat(16)9
Avg Revenue beat(16)0.45%
PT rev (1m)0%
PT rev (3m)-0.55%
EPS NQ rev (1m)45.23%
EPS NQ rev (3m)-1.22%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 193.22
Fwd PE 95.4
P/S 3.77
P/FCF 1984.82
P/OCF 41.76
P/B 3.72
P/tB 44.23
EV/EBITDA 35.67
EPS(TTM)0.18
EY0.52%
EPS(NY)0.36
Fwd EY1.05%
FCF(TTM)0.02
FCFY0.05%
OCF(TTM)0.83
OCFY2.39%
SpS9.22
BVpS9.36
TBVpS0.79
PEG (NY)1.88
PEG (5Y)N/A
Graham Number6.16
Profitability
Industry RankSector Rank
ROA 1.1%
ROE 2.18%
ROCE 3.41%
ROIC 2.26%
ROICexc 2.46%
ROICexgc 5.74%
OM 6.06%
PM (TTM) 2.21%
GM 64.4%
FCFM 0.19%
ROA(3y)-1.48%
ROA(5y)-1.76%
ROE(3y)-4.5%
ROE(5y)-5.02%
ROIC(3y)2.51%
ROIC(5y)N/A
ROICexc(3y)2.72%
ROICexc(5y)N/A
ROICexgc(3y)6.7%
ROICexgc(5y)N/A
ROCE(3y)3.8%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y12.65%
ROICexc growth 3YN/A
ROICexc growth 5Y23.53%
OM growth 3YN/A
OM growth 5Y12.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.07%
GM growth 5Y-0.57%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 260.47
Debt/EBITDA 4.43
Cap/Depr 173.84%
Cap/Sales 8.85%
Interest Coverage 0.95
Cash Conversion 81.05%
Profit Quality 8.6%
Current Ratio 3.53
Quick Ratio 2.62
Altman-Z 3.07
F-Score7
WACC8.7%
ROIC/WACC0.26
Cap/Depr(3y)84.09%
Cap/Depr(5y)70.92%
Cap/Sales(3y)4.61%
Cap/Sales(5y)4.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)141.86%
EPS 3YN/A
EPS 5Y-4.78%
EPS Q2Q%112.82%
EPS Next Y102.54%
EPS Next 2Y107.21%
EPS Next 3Y69.87%
EPS Next 5Y70.33%
Revenue 1Y (TTM)13.59%
Revenue growth 3Y12.04%
Revenue growth 5Y11.75%
Sales Q2Q%19.2%
Revenue Next Year11.86%
Revenue Next 2Y11.51%
Revenue Next 3Y11.73%
Revenue Next 5Y12.25%
EBIT growth 1Y-0.48%
EBIT growth 3YN/A
EBIT growth 5Y25.35%
EBIT Next Year219.45%
EBIT Next 3Y66.04%
EBIT Next 5Y45.21%
FCF growth 1Y-92.41%
FCF growth 3YN/A
FCF growth 5Y-30.14%
OCF growth 1Y79.35%
OCF growth 3YN/A
OCF growth 5Y26.38%

ARTIVION INC / AORT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ARTIVION INC?

ChartMill assigns a fundamental rating of 5 / 10 to AORT.


What is the valuation status for AORT stock?

ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.


What is the profitability of AORT stock?

ARTIVION INC (AORT) has a profitability rating of 5 / 10.


What is the financial health of ARTIVION INC (AORT) stock?

The financial health rating of ARTIVION INC (AORT) is 6 / 10.


Can you provide the expected EPS growth for AORT stock?

The Earnings per Share (EPS) of ARTIVION INC (AORT) is expected to grow by 102.54% in the next year.